Want to join the conversation?
$MNK said the company continues to be encouraged by the performance of Therakos, with net sales growth of 16% on a pro forma basis. Longer term, the company expects Therakos to settle more in the historical high single-digit range. $MNK added that the company is on track to launch RAPLIXA later this year.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?